Indinavir: all 52 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric SarcomasCompletedNCT00001566Phase 2Results posted
• External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesStatus unknownNCT00637637Phase 2
• The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving RifampicinCompletedNCT00411996Phase 1/2
• Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug IndinavirCompletedNCT00362310Phase 2
• Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVCompletedNCT00307502Phase 1
• A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and AmprenavirCompletedNCT00148785Phase 4
• Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy VolunteersCompletedNCT00050180Phase 4
• Ritonavir and Indinavir in Children Failing Other Anti-HIV TreatmentCompletedNCT00012519Phase 1/2
• Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV DrugsStatus unknownNCT00006397Phase 3
• A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV InfectionCompletedNCT00006154Phase 3
• The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention TreatmentStatus unknownNCT00005118Phase 2
• A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken IndinavirCompletedNCT00002452Phase 2
• Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV DrugsStatus unknownNCT00002451Phase 2
• A Study to Compare the Effectiveness of Two Anti-HIV Drug CombinationsCompletedNCT00002430Not applicable
• A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and LamivudineSuspendedNCT00002424Phase 2
• A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include AmprenavirCompletedNCT00002423Phase 2
• A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00002410Phase 3
• A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected PatientsCompletedNCT00002406Phase 3
• A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected PatientsCompletedNCT00002401Not applicable
• A Study of Two Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00002400Not applicable
• A Study of Indinavir Taken With or Without DMP 266CompletedNCT00002393Phase 3
• The Safety and Effectiveness of Indinavir Sulfate Plus EfavirenzCompletedNCT00002387Not applicable
• Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With HemophiliaCompletedNCT00002386Phase 4
• The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV DrugsCompletedNCT00002379Phase 2
• Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected PatientsCompletedNCT00002375Not applicable
• Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease InhibitorsCompletedNCT00002361Phase 2
• A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive PatientsCompletedNCT00002354Not applicable
• A Study of L-735,524 in HIV-Positive Children and AdolescentsCompletedNCT00002351Phase 1
• Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice DailyStatus unknownNCT00002241Phase 2
• A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive PatientsCompletedNCT00002236Not applicable
• A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease InhibitorsCompletedNCT00002235Phase 2
• A Study of a Combination of Four Drugs in Patients With Recent HIV InfectionCompletedNCT00002233Phase 2
• A Study of Ritonavir/Indinavir Combination in HIV-Infected PatientsCompletedNCT00002223Not applicable
• Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With NelfinavirCompletedNCT00002220Phase 3
• A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TCCompletedNCT00002208Phase 3
• A Comparison of 141W94 and Indinavir in HIV-Infected PatientsCompletedNCT00002202Phase 3
• The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of InfectionCompletedNCT00002179Phase 4
• A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV InfectionCompletedNCT00001443Phase 1
• Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or SaquinavirCompletedNCT00001133Phase 1
• A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected PatientsCompletedNCT00001086Phase 2
• A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected PatientsCompletedNCT00001084Phase 2
• Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV DrugsCompletedNCT00001083Phase 2
• A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000944Phase 1
• Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment RegimenCompletedNCT00000903Phase 3
• Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected ChildrenCompletedNCT00000901Phase 1
• Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320CompletedNCT00000885Phase 2
• Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced SubjectsCompletedNCT00000882Phase 2
• Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative AdultsCompletedNCT00000877Phase 1
• The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected PatientsCompletedNCT00000861Not applicable
• The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One YearCompletedNCT00000848Phase 2
• A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More MonthsCompletedNCT00000841Phase 3
• A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)WithdrawnNCT00000804Not applicable

← Indinavir overview